Various kinds of genetic abnormalities, such as KRAS mutation [75], EGFR mutation [32, 33], and ALK rearrangement [76–78], have been identified in CTCs from NSCLC patients. The gene discussed is ALK; the disease is non-small cell lung carcinoma.